Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Wearable Enhanced Fitness Tracking for Metastatic Breast Cancer Patients Using Endocrine Treatment and Palbociclib

NCT05277935 is registered in ClinicalTrials.gov with Beneficência Portuguesa de São Paulo as lead sponsor.

NCT NCT05277935
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05277935 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Wearable Enhanced Fitness Tracking for Metastatic Breast Cancer Patients Using Endocrine Treatment and Palbociclib
Lead sponsor
Beneficência Portuguesa de São Paulo
Phase
Not applicable
Overall status
Recruiting
Start date
April 22, 2022
Completion date
March 1, 2025
Enrollment
68 (estimated)
Sites
4

Conditions

As the registry lists them; a condition with its own page is linked.

breast neoplasm female, quality of life